https://www.selleckchem.com/pr....oducts/thapsigargin.
This study aims to determine whether comparable target regions of interest (ROIs) and cut-offs can be used across [ F]flortaucipir, [ F]RO948, and [ F]MK6240 tau positron emission tomography (PET) tracers for differential diagnosis of Alzheimer's disease (AD) dementia vs either cognitively unimpaired (CU) individuals or non-AD neurodegenerative diseases. A total of 1755 participants underwent tau PET using either [ F]flortaucipir (n = 975), [ F]RO948 (n = 493), or [ F]MK6240 (n = 287). SUVR values were calculated across four theory
Like
Comment
Share
